We collect and analyze sentiment surrounding BMY stock to help you make informed investment decisions.
Published on December 23, 2024
In a recent announcement, Stanley Lafferty, the renowned stock market analyst and founder of Stocks Prognosis, recommended buying shares of Bristol-Myers Squibb Company (BMY). Lafferty believes that BMY is poised for significant growth in the coming ...
Published on December 22, 2024
Bristol-Myers Squibb Company (BMY) has announced a strategic partnership with Fangzhou, a leading healthcare provider in China....
Published on December 22, 2024
Bristol-Myers Squibb Company (NYSE:BMY) announced today that it will be paying a larger dividend to its shareholders this year, compared to last year. The company's board of directors approved a dividend payment of $0.62 per share, representing an in...
Published on December 21, 2024
Bristol-Myers Squibb Company (NYSE: BMY) has recently announced a larger dividend payout for the fiscal year 2024, signaling strong financial performance and driving investor confidence. With a dividend of 0.62, the pharmaceutical giant aims to rewar...
Published on December 20, 2024
Bristol-Myers Squibb, a leading pharmaceutical company, has announced that it will be paying out a larger dividend to its shareholders this year. The company's dividend will be set at 0.62, which is higher than last year's payout. This news comes as ...
Published on December 20, 2024
Bristol-Myers Squibb Company (NYSE:BMY) has just announced that it will be paying a larger dividend than last year, showing its commitment to rewarding its shareholders. The biopharmaceutical giant will be paying out a dividend of $0.62 per share, an...
Published on December 19, 2024
Bristol-Myers Squibb Company (BMY) recently awarded a milestone payment of $25 million for the discovery of a breakthrough treatment target for ALS (Amyotrophic lateral sclerosis), also known as Lou Gehrig's disease. The significant achievement was m...
Published on December 18, 2024
Bristol-Myers Squibb Company (NYSE: BMY) has announced a larger dividend payment for shareholders compared to last year....
Published on December 17, 2024
Bristol-Myers Squibb (NYSE:BMY), a leading pharmaceutical company, has announced its 16th consecutive annual increase in dividends. This news comes as a pleasant surprise to shareholders who can now expect a larger payout compared to the previous yea...
Published on December 17, 2024
Bristol Myers Squibb, a leading pharmaceutical company, has recently announced its financial results for the quarter, reporting a strong performance and exceeding market expectations. The company has achieved a 10% increase in revenue compared to the...
Published on December 16, 2024
Bristol Myers Squibb Company, a leading pharmaceutical company, has made a significant announcement regarding its dividend streak. The company has extended its impressive 93-year dividend streak by announcing its 16th consecutive annual increase. Thi...
Published on December 15, 2024
Bristol Myers Squibb Company (BMY) has made its mark once again by extending its 93-year dividend streak with a 16th consecutive annual increase. This announcement comes as no surprise, considering the company's impressive track record and commitment...
Published on December 15, 2024
Bristol Myers Squibb (BMY) has been making waves in the pharmaceutical industry with its innovative treatments and life-saving medicines. Recently, Biogen, a leading biotechnology company, announced the appointment of Tim Power as the Head of Investo...
Published on December 14, 2024
Bristol Myers Squibb (BMY), a leading pharmaceutical company, has extended its impressive 93-year dividend streak with a 16th consecutive annual increase. This announcement comes as a reflection of the company's commitment to providing consistent ret...
Published on December 13, 2024
Bristol Myers Squibb Company (BMY) has recently announced its 16th consecutive annual dividend increase, extending its impressive 93-year dividend streak. This news has made BMY a top choice for socially responsible investors, as it offers a 4% yield...
Published on December 12, 2024
Bristol-Myers Squibb Company (BMY) has recently been in news due to its impressive financial performance and potential growth prospects. The company has shown resilience during the global pandemic and has continued to deliver strong results. Its robu...
Published on December 12, 2024
Bristol Myers Squibb, a renowned pharmaceutical company, has recently received a positive prognosis for its stock movement....
Published on December 11, 2024
Bristol-Myers Squibb Company, a renowned global biopharmaceutical corporation, is making waves in the investment market. With a 36....
Published on December 10, 2024
Bristol-Myers Squibb, a renowned pharmaceutical company, has recently announced a groundbreaking cancer treatment that has shown promising results in clinical trials. The treatment, named BMY-CURE, targets specific genetic mutations responsible for t...
Published on December 9, 2024
Bristol Myers Squibb Company (BMY), a leading pharmaceutical company, has entered into a groundbreaking research collaboration and option agreement with AI Proteins. This collaboration aims to revolutionize drug development using AI-driven technology...
Published on December 9, 2024
Bristol-Myers Squibb Company, commonly known as BMY, has been making waves in the investment world....
Published on November 11, 2024
On October 8, 2024, QuantWave's forecast signal indicated a long position for BRISTOL-MYERS SQUIBB COMPANY (BMY) with a price of $51.35. Investors who followed the prediction saw the stock reach the target price of $58.53 on November 11, 2024, result...
Published on November 11, 2024
On October 22, 2024, QuantWave issued a forecast signal for BRISTOL-MYERS SQUIBB COMPANY with a price target of $58....
Published on November 11, 2024
QuantWave, a leading automated forecasting platform, recently achieved a significant milestone in its price target forecast for BRISTOL-MYERS SQUIBB COMPANY. The forecast signal was initiated on October 29, 2024, with the stock trading at 51.37 $. Th...
Published on November 11, 2024
On October 8, 2024, QuantWave's automated forecasting platform issued a long signal for BRISTOL-MYERS SQUIBB COMPANY with a price of $50.68. Fast forward to November 11, 2024, and the stock successfully reached the forecasted target price of $57.77, ...